Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG-SN + Aspirin in Pediatric Kawasaki Disease
NCT01524939Phase 4Completed
- Sponsor
- GC Biopharma
- Start
- Jan 2012
- Primary completion
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of IVIg-SN 10% in Kawasaki disease (KD), sponsored by GC Biopharma. Started Jan 2012; status: completed.
02
Drugs
IVIg-SN 10%
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NCT01524939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524939.